MUMBAI, India, July 13 -- Intellectual Property India has published a patent application (202647082984 A) filed by Heidelberg Pharma Research Gmbh on July 06, 2026, for Modular Linker Compound For Target-Binding Drug Conjugates.
Inventors include Mller, Christoph; Gruss, Hendrik; Hechler, Torsten; and Petrich, Valentin.
The application for the patent was published on July 10, 2026, under issue no. 28/2026.
Abstract: The present invention relates to modular linker compounds for target-binding drug conjugates (TBDCs) and in particular to modular linker compounds for antibody-drug-conjugates (ADCs). The modular linker compounds comprise solubility enhancing groups and self-immolative spacers. The invention further relates to methods of synt...